Profiling of Post Covid-19 Infection Patients: an Online Survey
PRESTO
1 other identifier
observational
567
1 country
1
Brief Summary
The aim of this study is to explore the relation between indicators of central sensitisation, quality of life and functional status in patients post covid-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2021
CompletedFirst Posted
Study publicly available on registry
June 3, 2021
CompletedStudy Start
First participant enrolled
June 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2021
CompletedSeptember 23, 2021
September 1, 2021
3 months
June 2, 2021
September 22, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Functional status
Post-COVID-19 functional status is evaluated by the Post-COVID-19 Functional Status Scale.
Up to 18 months after infection with Covid-19.
Health-related Quality of life
The EuroQol with five dimensions and three levels is used to evaluate health-related quality of life.
Up to 18 months after infection with Covid-19.
Symptoms of central sensitisation
Symptoms of central sensitisation are assessed by the Central Sensitization Inventory.
Up to 18 months after infection with Covid-19.
Study Arms (1)
Persons who had a covid-19 infection.
Male and female adults who were previously infected with covid-19.
Interventions
Patients are asked to fill in an online survey regarding functional status, quality of life and symptoms of central sensitisation.
Eligibility Criteria
In this study male and female adults who were previously infected with covid-19 will be eligible to complete the survey. No specific criteria will be imposed regarding the time frame after infection.
You may qualify if:
- male and female adults who were previously infected with covid-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Moens Maartenlead
- STIMULUS research group, Vrije Universiteit Brusselcollaborator
Study Sites (1)
Universitair Ziekenhuis Brussel
Jette, 1090, Belgium
Related Publications (1)
Moens M, Duarte RV, De Smedt A, Putman K, Callens J, Billot M, Roulaud M, Rigoard P, Goudman L. Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients. Front Public Health. 2022 Oct 20;10:991572. doi: 10.3389/fpubh.2022.991572. eCollection 2022.
PMID: 36339175DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
June 2, 2021
First Posted
June 3, 2021
Study Start
June 4, 2021
Primary Completion
August 30, 2021
Study Completion
August 30, 2021
Last Updated
September 23, 2021
Record last verified: 2021-09